check_circleStudy Completed

Postmenopause, Pharmacokinetics

Study to evaluate the bioavailability of Estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2)

Trial purpose

Please see attached Study Results Summary below.

Key Participants Requirements

Sex

N/A

Age

N/A

Trial summary

Enrollment Goal
15
Trial Dates
October 2003 - January 2004
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Climara (E2 transdermal, BAY86-5435)
Accepts Healthy Volunteer
N/A

Primary Outcome

Secondary Outcome

Trial design

An open-label, randomized, crossover study to evaluate the bioavailability of estradiol after single application of two different Climara® estradiol transdermal systems (SH P00577F, 9.375 cm2 and SH P00577G, 15.0 cm2) in healthy postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A